Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
72
CIMA_AEMPS:43
NMPA:23
SFDA:6
Drug Approvals
Mivacurium Chloride Injection
- Product Name
- 美维松
- Approval Number
- 国药准字HJ20181155
- Approval Date
- Jan 6, 2025
NMPA
Mivacurium Chloride Injection
- Product Name
- 美维松
- Approval Number
- 国药准字HJ20181156
- Approval Date
- Jan 6, 2025
NMPA
Propofol Injectable Emulsion
- Product Name
- 得普利麻
- Approval Number
- 国药准字HJ20171273
- Approval Date
- Dec 20, 2024
NMPA
Propofol Injectable Emulsion
- Product Name
- 得普利麻
- Approval Number
- 国药准字HJ20171277
- Approval Date
- Dec 20, 2024
NMPA
Propofol Injectable Emulsion
- Product Name
- 得普利麻
- Approval Number
- 国药准字HJ20171275
- Approval Date
- Dec 20, 2024
NMPA
Propofol Injectable Emulsion
- Product Name
- 得普利麻
- Approval Number
- 国药准字HJ20171278
- Approval Date
- Dec 20, 2024
NMPA
Fludrocortisone Acetate Tablets
- Product Name
- 醋酸氟氢可的松片
- Approval Number
- 国药准字HJ20240027
- Approval Date
- May 21, 2024
NMPA
Nadroparin Calcium Injection
- Product Name
- 速碧林
- Approval Number
- 国药准字HJ20181135
- Approval Date
- Jul 24, 2023
NMPA
Nadroparin Calcium Injection
- Product Name
- 速碧林
- Approval Number
- 国药准字HJ20181137
- Approval Date
- Jun 29, 2023
NMPA
Nadroparin Calcium Injection
- Product Name
- 速碧林
- Approval Number
- 国药准字HJ20181136
- Approval Date
- Jun 29, 2023
NMPA
- Prev
- 1
- 2
- 3
- Next
Clinical Trials
No trials found
News
No news found